Curious2018

Creating a Better World with Science & Technology: Further Pushing the Boundaries of Possibility.- Building a Better World with Science and Technology - Curious Future Insight.- Future Insight Prize - From Dream to Reality.- Curious2018 - Future Insight.- The Darmstadt Science Declaration - Make Science Not War. Science & Technology at its Best - Examples from Curious2018 Future Insight Conference Keynote Speakers: Integrating Modern Immunology into Medicine.- The Changing Landscape for New Drug Development: Medical Countermeasures (Mcms) as a Case Study.- In The Face of Global Health Challenges - Let's Redefine Innovation.- Neglected Parasitic Infections and the Syndemic Anemia Vaccines for Africa.- Out of Curiosity - From Blue Sky Research to Medical Innovation.- From Diagnosing Diseases to Predicting Diseases.- Colloidal Quantum Materials for Photocatalytic Applications.- Vibrant Digital - A Personal Journey Navigating the Cognitive Era.- Accelerating Discovery With Cognitive - An Example Cognitive Application for Discovery. Bright Future Foresight Driven Policymaking: Society 5.0.- Curiosity - Fuel for Innovation.- The Way Forward.

Dr. Ulrich A.K. Betz, Vice President of Innovation at Merck, is responsible for innovation management and strategic academic collaborations. He is an accomplished R&D manager with more than 20 years of experience in the pharmaceutical and chemical industry, including positions in the President's Office at Merck Biopharma, and positions reporting directly to the Heads of Research and Development at Bayer and Merck. In his current role, for example, he designed and implemented the Merck Innovation Cup, the Curious2018 - Future Insight Conference, the Merck Future Insight Prize, the Darmstadt Science Declaration, the idea competition innospire and the BioMed X Outcubator. Prior to joining Merck in 2005, he worked at Bayer AG for seven years, in various scientific and managerial positions in Pharma Research. Ulrich received his PhD in functional genomics and immunology from the University of Cologne, Germany, and his diploma in biochemistry and physiological chemistryfrom the University of Tübingen, Germany. He is a co-inventor of the marketed anti-viral drug Letermovir (Prevymis) and of Pritelivir (Phase II). Ulrich has won several innovation awards such as the German Industry Innovation Award (the world's oldest innovation award), two International Business Awards (Stevie Gold Awards Executive of the Year - Pharmaceuticals and Innovator of the Year), a Stevie Gold Germany Award (R&D Manager of the Year Germany), Edison Award, the Bio IT World Best Practice Award, and the German Idea Award. Ulrich is the author or co-author of over 90 publications (e.g. in Cell, Nature Medicine, and Nature Biotechnology).